You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ixazomib

Showing 26 - 50 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Multiple Myeloma Trial in Odense (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • Odense, Denmark
    Odense University Hospital
Nov 18, 2021

Glioblastoma Trial in Atlanta (Ixazomib)

Completed
Has Results
  • Glioblastoma
  • Ixazomib
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 2, 2021

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Ixazomib
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Boston, Danvers, Newton (Nivolumab, Ixazomib, Dexamethasone)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
May 14, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Ixazomib
  • +3 more
  • Little Rock, Arkansas
  • +23 more
Feb 24, 2022

Newly Diagnosed Multiple Myeloma Trial in West Hollywood (Ixazomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • West Hollywood, California
    James R Berenson, MD, Inc.
Oct 23, 2020

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

Multiple Myeloma Trial in Toulouse (Ixazomib, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Toulouse, France
    University Hosptial Toulouse
Nov 9, 2020

Lymphoma, T-Cell, Peripheral Trial in United States (Romidepsin, Ixazomib)

Active, not recruiting
  • Lymphoma, T-Cell, Peripheral
  • Chicago, Illinois
  • +6 more
Jan 15, 2021

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Ixazomib
  • +2 more
  • Nagoya, Aichi, Japan
  • +20 more
Dec 18, 2020

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Waldenstrom's Macroglobulinemia Trial in Boston (Ixazomib, Dexamethasone, Rituximab)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Ixazomib
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 20, 2020

Advanced Solid Tumors, Lymphoma Trial in Cleveland (IXAZOMIB)

Completed
Has Results
  • Advanced Solid Tumors
  • Lymphoma
  • IXAZOMIB
  • Cleveland, Ohio
    (unnamed)
Aug 25, 2020

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Tucson, Arizona
  • +32 more
Oct 8, 2021

Triple-Negative Breast Cancer Trial in Austria (Ixazomib, Carboplatin)

Terminated
  • Triple-Negative Breast Cancer
  • Wels, Oberösterreich, Austria
  • +11 more
Nov 26, 2020

Precursor Cell Lymphoblastic Leukemia-lymphoma Trial in Spain, United States (Ixazomib)

Withdrawn
  • Precursor Cell Lymphoblastic Leukemia-lymphoma
  • Ixazomib
  • Jackson, Mississippi
  • +6 more
Sep 24, 2020

Multiple Myeloma Trial in New York (ONC201, Ixazomib, Dexamethasone)

Terminated
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 27, 2020

Multiple Myeloma Trial in France (Ixazomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Ixazomib
  • +3 more
  • Bordeaux, France
  • +11 more
Jul 29, 2020

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Ixazomib, Ixazomib Citrate, Rituximab)

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Ixazomib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2020

Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Placebo
  • Ixazomib
  • Fountain Valley, California
  • +274 more
Jan 13, 2023

Multiple Myeloma Trial in Brazil (Ixazomib, Thalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Salvador, BA, Brazil
  • +5 more
Jan 10, 2020